title: Improving efficiency of ALS clinical trials: a sponsor's perspective.
authors.affiliation: Novartis Pharma AG, 4002 Basel, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Markabi
authors.forename: J
authors.initials: J
authors.lastname: Schadrack
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D015415:Biomarkers; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D012107:Research Design
chemical_list: D015415:Biomarkers